Ferroelectric transducer arrays for transdermal insulin delivery
The goal of this research was the development of a portable therapeutic device for the treatment of diabetes. A 3×3 cymbal array has been successfully tested in noninvasive insulin delivery experiments. The cymbal is a composite flextensional transducer constructed from a poled PZT ceramic and shaped metal endcaps that amplify the transducer motions by two orders of magnitude. Nine cymbals are wired in parallel and potted in polyurethane to form the flat panel arrays. When driven near resonance (20 kHz), the array generated a low intensity acoustic beam of 100 mW/cm2. Animal experiments on hyperglycemic rats and rabbits demonstrated the ultrasonic enhancement of transdermal insulin delivery.
KeywordsInsulin Delivery Normalize Blood Glucose Level Cymbal Transducer Piezoelectric Ceramic Disk Ultrasonic Enhancement
Unable to display preview. Download preview PDF.
- 2.W. J. TOULIS, Us Patent 3,277,433 (1966).Google Scholar
- 4.J. F. TRESSLER, Q. C. XU, S. YOSHIKAWA, K. UCHINO and R. E. NEWHAM, Ferroelectrics 156 (1994) 67.Google Scholar
- 5.A. DOGAN, K. UCHINO and R. E. NEWHAM, IEEE UFFC 44 (1997) 597.Google Scholar
- 7.American Diabetes Association, Diabetes Care 26(Supp. 1) (2003) s121.Google Scholar
- 12.R.E. NEWNHAM and A. DOGAN, US Patent 5,729,077 (1995).Google Scholar
- 13.R.E. NEWNHAM and J. ZHANG, US Patent 6,232,702 (1999).Google Scholar
- 14.S. LEE, “Ultrasound-Mediated Transdermal Insulin Delivery and Glucose Measurement Using the Cymbal Array,” Ph.D. Thesis, Penn State University (2004).Google Scholar